India's drug pricing regulator, NPPA, is increasing scrutiny of pharmaceutical companies seeking price exemptions. The NPPA is collaboratin...

Around 92,000 patent applications were filed in India in the last financial year. This showcases India's progress as a technological hub. T...

Controller General of Patents, Designs and Trade Marks (CGPDTM) said that candidates who are willing to appear in trademark and patent agen...

Piyush Goyal was addressing participants of the National IP conference and awards function, organised by the department for promotion of in...

The CCI has received certain complaints alleging predatory pricing against e-commerce companies, Minister of State for Commerce and Industr...

A Department of Industrial Policy and Promotion (DIPP) official said that a "good suggestion" on state IPR policy was made during the sessi...

The Modi government, in its push for Make in India', has announced a slew of measures to promote homegrown talent.

There are 680 drug formulations related to 348 bulk drugs listed in NLEM by National Pharmaceutical Pricing Authority (NPPA).

India's patent authority has called for proposals to provide one-point access to databases of patent and non-patent literature of all count...

The government is looking to appoint 250 more examiners by April, 2012, thereby reducing the time taken for approvals by one-third by 2016.

In a major modification to the patent rules, the government has decided to make all applications for patents public 18 months after the dat...